Fig 1. Reader preference for gadobenate dimeglumine or gadodiamide based on blinded qualitative evaluation. Each reader expresses a highly significant (P < .0001) preference for gadobenate dimeglumine for each parameter. Note that the number of patients for whom equality is expressed is not shown.